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Summary 20
Many methods have been recently proposed for ecient analysis of case{control studies
of gene-environment interactions using a retrospective likelihood framework that exploits
the natural assumption of gene-environment independence in the underlying population.
However, for polygenic modeling of gene-environment interactions, a topic of increas-
ing scientic interest, applications of retrospective methods have been limited due to 25
a requirement in the literature for parametric modeling of the distribution of the ge-
netic factors. We propose a general, computationally simple, semiparametric method
for analysis of case{control studies that allows exploitation of the assumption of gene{
environment independence without any further parametric modeling assumptions about
the marginal distributions of any of the two sets of factors. The method relies on the 30
key observation that an underlying ecient prole likelihood depends on the distribution
of genetic factors only through certain expectation terms that can be evaluated empiri-
cally. We develop asymptotic inferential theory for the estimator and evaluate numerical
performance using simulation studies. An application of the method is presented.
Some key words: Case-control studies; Gene-environment interactions; Genetic epidemiology; Pseudolike- 35
lihood; Retrospective studies; Semiparametric methods.
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21. Introduction
Recent genome-wide association studies indicate that complex diseases, such as can-
cers, diabetes and heart diseases, are in general extremely polygenic (Chatterjee et al.,
2016; Fuchsberger et al., 2016). Genetic predisposition to a single disease may involve40
thousands of genetic variants, each of which may have a very small eect individually, but
in combination they can explain substantial variation in risk in the underlying population.
As discoveries from genome-wide association studies continue to enhance understanding
of complex diseases, in the future, it will be critical to understand how these genetic fac-
tors interact with environmental risk factors for both understanding disease mechanisms45
and developing public health strategies for disease prevention.
Because of its sampling eciency, the case{control design is widely popular for con-
ducting studies of genetic associations and gene{environment interactions. A variety of
analytic methods have been proposed to increase the eciency of analysis of case{control
data for studies of gene{environment interactions by exploiting an assumption of gene{50
environment independence in the underlying population. It has been shown that under
the assumptions of gene{environment independence and rare disease, the interaction
odds-ratio parameters of a logistic regression model can eciently be estimated based on
cases alone (Piegorsch et al., 1994). A general logistic regression model can be t to case{
control data under the gene{environment independence assumption using a log-linear55
modeling framework (Umbach & Weinberg, 1997) or a semiparametric retrospective pro-
le likelihood framework (Chatterjee & Carroll, 2005). More recently, the assumption
of gene{environment independence has been exploited to propose a variety of powerful
hypothesis testing methods for conducting genome-wide scans of gene{environment inter-
actions (Murcray et al., 2009; Mukherjee & Chatterjee, 2008; Han et al., 2015; Mukherjee60
et al., 2012; Gauderman et al., 2013; Hsu et al., 2012).
We consider developing methods for ecient analysis of case{control studies for mod-
eling gene{environment interactions involving multiple genetic variants simultaneously.
To develop parsimonious models for joint eects, many studies have recently focused
on developing models for gene{environment interactions using underlying polygenic risk65
scores that could be dened by all known genetic variants associated with the diseases
(Meigs et al., 2008; Wacholder et al., 2010; Dudbridge, 2013; Chatterjee et al., 2013,
2016). Further, for obtaining improved biological insights and for enhancing statistical
power for detection, it may often be desired to model gene{environment interactions
using multiple variants within genomic regions or/and biologic pathways (Chatterjee70
et al., 2006; Jiao et al., 2013; Lin et al., 2013, 2015). In standard prospective logistic
regression analysis, which conditions on both the genetic and environmental risk factor
status of the individuals, handling multiple genetic variants is relatively straightforward.
In contrast, with retrospective methods, which aim to exploit the assumption of gene{
environment independence, the task becomes complicated because all currently existing75
methods require parametric modeling of the distribution of the genetic or environmental
variables.
We propose computationally simple methodology for tting general logistic regression
models to case{control data under the assumption of gene{environment independence,
but without requiring any further modeling assumptions about the distributions of the80
genetic or environmental variables. We extend the Chatterjee{Carroll prole likelihood
framework, which originally considered modeling gene{environment interactions using
single genetic variants for which genotype status could be specied using parametric
3multinomial models. The new method relies on the observation that the prole likelihood
itself can be estimated based on an empirical genotype distribution that is estimable 85
from a case{control sample. We develop the asymptotic theory of the resulting estimator
under a semiparametric inferential framework. Simulations and an example illustrate the
properties of the new methodology.
2. Model, Method and Theory
21. Background, model and method 90
In the following, we use notation similar to that of Chatterjee & Carroll (2005). We will
denote disease status, genetic information and environmental risk factors by D, G and
X, respectively. Here G may correspond to a complex multivariate genotype associated
with multiple genetic variants or a continuous polygenic risk score that is dened a priori
based on known associations of the genetic variants with the disease. We assume the risk 95
of the disease given genetic and environmental factors in the underlying population can
be specied using a model of the form
pr(D = 1 j G;X) = Hf0 +m(G;X; )g; (1)
where H(x) = f1 + exp( x)g 1 is the logistic distribution function and m(G;X; ) is a
parametrically specied function that denes a model for the joint eect of G and X
on the logistic-risk scale. The goal of the gene{environment interaction study is to make 100
inference on the parameters  in (1), including interaction parameters.
Let F (G;X) denote the joint distribution of G and X in the underlying population.
The key assumption that genetic, G, and environmental factors, X, are independently
distributed in the underlying population can be mathematically stated as
dF (G;X) = dFG(G) dFX(X);
where FG and FX denote the underlying marginal distributions of G and X, respectively. 105
In the Supplementary Material we discuss how to weaken this assumption by suitable
conditioning on additional stratication factors. In contrast to the existing literature,
here we assume that the marginal distributions FG(G) and FX(X) are both completely
unspecied.
We consider a population-based case{control study, in which (G;X) are sampled in- 110
dependently from those with the disease, called cases, and those without the disease,
called controls. Suppose there are n1 cases and n0 controls. Standard prospective logistic
regression analysis, which is equivalent to maximum-likelihood estimation when F (G;X)
is allowed to be completely unspecied, yields consistent estimates of  (Prentice & Pyke,
1979). 115
The retrospective likelihood is the probability of observing the genetic and environmen-
tal variables, given the subject's disease status. Under gene{environment independence
in the underlying population, the retrospective likelihood is
pr(G = g;X = xjD = d) = pr(D = djG = g;X = x)pr(G = g)pr(X = x)=pr(D = d):
Let fG() and fX() represent the density/mass functions of G and X, respectively. The
retrospective likelihood is 120
fG(g)fX(x) exp[df0 +m(g; x; )g]=[1 + expf0 +m(g; x; )g]R
fG(u)fX(v) exp[df0 +m(u; v; )g]=[1 + expf0 +m(u; v; )g]dudv : (2)
4Chatterjee & Carroll (2005) proled out fX() by treating it as discrete on the set of
distinct observed values (x1; : : : ; xm) of X with probabilities i = pr(X = xi), and then
maximized (2) over (1; : : : ; m), leading eventually to the semiparametric prole likeli-
hood described as follows. Dene  = 0 + log(n1=n0)  log(1=0), where 1 = 1  0 =
pr(D = 1) is dened as the probability of the disease in the underlying population. Dene125

 = (;T)T. Also dene
S(d; g; x;
) =
exp[df+m(g; x; )g]
1 + expf+ log(1=0)  log(n1=n0) +m(g; x; )g :
Then, with this notation, the semiparametric prole likelihood is
L(D;G;X;
; fG) = fG(G)
S(D;G;X;
)P1
d=0
R
fG(v)S(d; v;X;
)dv
: (3)
While the representation in (3) does not involve the unknown density of X, it does
involve the unknown density of G. This is a major reason that the current literature
species a parametric distribution for G. Our task in this paper is to dispense with the130
need to give a parametric form for the distribution function of G, so that analysis can
be performed with respect to potentially complex multivariate genotype data for which
parametric modeling can be dicult and cumbersome.
Here is our key insight, which we discuss rst in the context that 1 is known or at least
can be estimated well. For case{control studies that are conducted within well dened135
populations, relevant probabilities of the disease can be ascertained based on population-
based disease registries. When case{control studies are conducted by sampling of subjects
within a larger cohort study, the probability of the disease in the underlying population
can be estimated using the disease incidence rate observed in the cohort.
Our key insight in treating the distribution of G as nonparametric concerns the term140
in the denominator of (3), dened as
R(x;
) =
P1
r=0
Z
fG(v)S(r; v; x;
)dv:
This is simply the expectation, in the source population, of
P1
r=0 S(r;G; x;
). That
is, R(x;
) = Epopf
P1
r=0 S(r;G; x;
)g, where the subscript pop emphasizes that the
expectation is in the source population, not the case{control study. However, crucially,
R(x;
) = 1Ef
P1
r=0S(r;G; x;
) j D = 1g+ 0Ef
P1
r=0S(r;G; x;
) j D = 0g: (4)
Of course, R(x;
) is unknown, but we estimate it unbiasedly and nonparametrically by145
bR(x;
) =Pnj=1P1r=0P1d=0(d=nd)I(Dj = d)S(r;Gj ; x;
): (5)
In the Supplementary Material, we show that bR(x;
) is an unbiased estimate of R(x;
),
that is n1=2-consistent, and that it is asymptotically normally distributed.
Ignoring the leading term fG(G) in (3), which is not estimated, and taking logarithms,
leads us to an estimated loglikelihood in 
 across the data as
L(
) =Pni=1logS(Di; Gi; Xi;
) Pni=1log bR(Xi;
): (6)
5Dene S
(d; g; x;
) = @S(d; g; x;
)=@
 and similarly for bR
(x;
). Then the estimated 150
score function, a type of estimated estimating equation, is
bSn(
) = n 1=2 nX
i=1
(
S
(Di; Gi; Xi;
)
S(Di; Gi; Xi;
)
 
bR
(Xi;
)bR(Xi;
)
)
: (7)
Dene
Sn(
) = n 1=2
nX
i=1

S
(Di; Gi; Xi;
)
S(Di; Gi; Xi;
)
  R
(Xi;
)
R(Xi;
)

;
which is the prole loglikelihood score function when the distribution of G is known.
Since the prole loglikelihood score of Chatterjee & Carroll (2005) would have mean zero
if the distribution of G were known, it follows that 155
E fSn(
)g = 0; (8)
where the expectation in (8) is taken in the case{control study, not in the source popula-
tion. Thus, since bR(x;
) and bR
(x;
) converge in probability to R(x;
) and R
(x;
),
respectively, a consistent estimate of 
 can be obtained by solving bSn(
) = 0. This es-
timate b
, which maximizes the semiparametric pseudolikelihood (6), will be referred to
as the semiparametric pseudolikelihood estimator. 160
22. Rare diseases when 1 is unknown
When the probability of disease in the source population is unknown, one can in-
voke a rare disease assumption which is often reasonable for case{control studies
(Piegorsch et al., 1994; Modan et al., 2001; Epstein & Satten, 2003; Lin & Zeng, 2006;
Kwee et al., 2007; Zhao et al., 2003). If we assume that 1  0, then S(d; g; x;
)  165
exp[df+m(g; x; g], and the expectation involved in calculation of R(X;
) can be
evaluated based on the sample of controls, with D = 0, only. In this case, the estimates
of 
 converge not to 
 itself, but instead to 
, the solution to (8) with 1 = 0. Typically,
except when the sample size is very large and hence standard errors are unusually small,
the small possible bias of the rare disease approximation is of little consequence and 170
coverage probabilities of condence intervals remain near nominal, see x3 for examples.
The asymptotic theory of x23 below is then unchanged.
In the Supplementary Material, we show that the score and the Hessian take on simple
forms in this case, and that the Hessian is negative semidenite. Computation is thus
very ecient. 175
23. Asymptotic theory
To state the asymptotic results, we rst make the denitions
 1 =
P1
d=0(nd=n)E

@S
(D;G;X;
)=S(D;G;X;
)
@
T
D = d ;
 2 =
P1
d=0(nd=n)E

@R
(X;
)=R(X;
)
@
T
D = d :
In addition, dene cd = nd=n, Zi = (Di; Gi; Xi), P1(Xi;
) = 1=R(Xi;
) and
P2(Xi;
) = R
(Xi;
)=R
2(Xi;
).
6We use the notational convention that for arbitrary functions (P; T ), TE(r; d; x) =180
EfT (r;G; x) j D = dg. Also, we use the convention that
E [P (X) fT (r; gi; X)  TE(r; d;X)g j D = t]
= E [P (X) fT (r; g;X)  TE(r; d;X)g j D = t]g=Gi :
Dene
(Zi;
) =
S
(Zi;
)
S(Zi;
)
  R
(Xi;
)
R(Xi;
)
 
1X
d=0
1X
r=0
cddi
cdi
E [fP1(X;
)S
(r; gi; X)  P2(X;
)S(r; gi; X)g j D = d] :
Finally, dene (Zi;
) = (Zi;
)  Ef(Z;
) j D = Dig.
Theorem 1. Suppose nd=n! cd, where 0 < cd <1, and that 1 is known. Then
n1=2(b
  
) =  ( 1    2) 1n 1=2Pni=1(Zi;
) + op(1): (9)
Thus, since the Zi are independent and Ef(Z;
) j Dig = 0,185
n1=2(b
  
)! N 0; ( 1    2) 1f( 1    2) 1gT ;
 =
P1
d=0(nd=n)covf(D;X;G;
) j D = dg
=
P1
d=0(nd=n)covf(D;X;G;
) j D = dg:
In x22, when 1 is unknown and the disease is relatively rare, the same result holds
by setting 1 = 0.
3. Simulations
31. Overview
In our simulations, m(G;X; ) = GTG +XX + (GX)
TGX and the value of X is190
binary with population frequency 0:5. There are either three or ve correlated single
nucleotide polymorphisms within a region: we report the latter case, but the results for
the former are similar. Each single nucleotide polymorphism takes on the values 0, 1 or 2
following a trinomial distribution that follows Hardy{Weinberg equilibrium, i.e., the jth
component of G equals 0, 1, 2 with probabilities f(1  pj)2; 2pj(1  pj); p2jg. The values195
of the pj are described below.
To generate correlation among the single nucleotide polymorphisms, we rst generated
a 3 or 5-variate multivariate normal variate, each with mean 0 and standard deviation 1,
and a correlation matrix with correlation between the jth and kth component = jj kj,
where  = 0:7. After generating these random variables, we trichotomized them with200
appropriate thresholds so that frequency of 0, 1 and 2 matched those specied by the
allele frequency pj and Hardy{Weinberg equilibrium.
7Table 1: Results of 1000 simulations as described in x3, with mean bias, coverage prob-
abilities of a 95% nominal condence interval, and mean squared error eciency of our
semiparametric pseudolikelihood estimator compared to ordinary logistic regression. The
simulations were performed with 1000 cases and 1000 controls.
G1 G2 G3 G4 G5 X G1X G2X G3X G4X G5X
True 0.18 0.18 0.00 0.18 0.00 0.41 0.26 0.00 0.00 0.26 0.00
Logistic: 1000 cases
Bias 0.00 0.01 0.00 0.01  0.01 0.01 0.01  0.01 0.00 0.00 0.01
CI (%) 94.3 95.2 95.7 95.1 94.7 94.6 94.9 94.2 94.5 96.0 94.2
SPMLE, Rare: 1000 cases
Bias 0.01 0.00 0.00 0.02  0.01 0.02  0.02  0.01 0.01  0.02 0.01
CI (%) 95.2 95.4 96.4 95.8 95.3 95.1 95.4 94.8 96.1 95.5 94.9
Avg MSE E All G: 1.28 X: 1.26 All G X: 2.18
SPMLE, 1 known: 1000 cases
Bias 0.00 0.00 0.00 0.01  0.01 0.01 0.00  0.01 0.01  0.01 0.01
CI (%) 95.1 95.5 96.4 95.8 95.0 95.5 95.6 94.6 95.9 95.2 94.5
Avg MSE E All G: 1.28 All X: 1.28 All G X: 2.07
Logistic is ordinary logistic regression; SPMLE, Rare is our estimator using the rare disease approximation
with unknown 1 (x22); SPMLE, 1 known is our estimator when 1 is known in the source population
(x21); CI (%) is the coverage in percent of a nominal 95% condence interval (calculated using the
asymptotic standard error); Avg MSE E is the mean squared error eciency of our method compared
to logistic regression averaged over G (All G), overX (AllX) and over the G X (All G X) interactions.
In both simulations, the logistic intercept 0 was chosen so that the population dis-
ease rate 1 = 0:03. However additional simulations with 1 = 0:01 yielded very sim-
ilar results with regards to coverage, eciency gains, and unbiasedness. See also x33 205
for a discussion of additional simulations, and the Supplementary Material. In the
simulation reported here, (p1; p2; p3; p4; p5) = (0:1; 0:3; 0:3; 0:3; 0:1), X = log(1:5), G =
flog(1:2); log(1:2); 0:0; log(1:2); 0:0g, and GX = flog(1:3); 0:0; 0:0; log(1:3); 0:0g. Here the
value of 0 =  4:14.
32. Results 210
The standard error estimators used in our simulation were based on the asymptotic
theory described in Theorem 1: we also used the bootstrap, with very similar results.
The appropriate bootstrap in a case{control study is to resample the cases and controls
separately, thus maintaining the sample sizes for each.
The simulation results are presented in Table 1. Our semiparametric pseudolikelihood 215
estimator has little bias and coverage percentages near the nominal level. Both with
a rare disease approximation and with 1 known, our semiparametric pseudolikelihood
estimator achieves approximately a 25% increase in mean squared error eciency over
ordinary logistic regression for the main eects in both G and X.
Strikingly, the mean squared error eciency of our semiparametric pseudolikelihood 220
estimators compared to ordinary logistic regression is approximately 2:00 for all the inter-
action terms, thus demonstrating that our methods, which do not model the distribution
of either G or X, achieve numerically signicant increases in eciency.
833. Additional simulations
The Supplementary Material presents a series of additional simulations. These include225
the results of a simulation to evaluate the robustness of our method to misspecication
of the population disease rate, where we found a surprising robustness to disease rate
misspecication. Additionally, there are simulations to examine the robustness of our
method to violations of the gene{environment independence assumption. Those simu-
lation studies show that there will be bias in the estimate of gene{environment inter-230
action parameters for the specic single nucleotide polymorphisms under violation of
gene{environment independence, but average mean square error for parameter estimates
across all the dierent single nucleotide polymorphisms could be still substantially lower
than that obtained from prospective logistic regression analysis. We also show there how
to remove this bias when G and E are independent conditional on a discrete strati-235
cation variable. Mukherjee & Chatterjee (2008) and Chen et al. (2009) show how to
use empirical-Bayes methods to provide additional robustness to violations of the gene{
environment independence assumption.
4. Data Analysis
In this section, we apply our methodology to a case{control study for breast cancer240
arising from a large prospective cohort at the National Cancer Institute: the Prostate,
Lung, Colorectal and Ovarian cancer screening trial (Canzian et al., 2010). The design
of this study is described in detail by Prorok et al. (2000) and Hayes et al. (2000).
The cohort data consisted of 622; 449 women, of whom 3.56% developed breast cancer
(Pfeier et al., 2013). The case{control study analyzed here consists of 753 controls and245
658 cases. Although 1 is known in this population, we analyze the data both with 1
known and with 1 unknown but with a rare disease approximation.
We had data available on genotypes for 21 single nucleotide polymorphisms that have
been previously associated with breast cancer based on large genome-wide association
studies. The polygenic risk score was dened by a weighted combination of the geno-250
types, with the weights dened by log-odds-ratio coecients reported in prior studies.
We examined the interaction of the polygenic risk score with age at menarche (X), a
known risk factor for breast cancer, dened as the binary indicator of whether the age at
menarche exceeds 13 or not. We also adjust the model for age as a continuous variable,
denoted here as Z, so that the model tted is255
pr(D = 1) = H(0 + GG+ XX + GXGX + ZZ): (10)
Results in which age was categorized as < 35, 35-40, 40-45,. . . ,> 75 were similar.
We also performed analyses to check the gene{environment independence assumption.
Since X is binary, we ran a t-test of the polygenic risk score against the levels of X,
of course among the controls only. The p-value was 0.91, indicating almost no genetic
eect. We also ran chisquared tests for the 21 individual genes, nding no signicant260
association after controlling the false discovery rate: the minimum q-value was 0.09. We
also checked for correlation, known as linkage disequilibrium, between the 21 loci used to
create the polygenic risk score and 32 loci that are known to inuence age at menarche
(Elks et al., 2010). The data available to us do not have the necessary information to
analyze linkage disequilibrium between the two sets of loci.265
9Table 2: Results of the analysis of the Prostate, Lung, Colorectal and Ovarian cancer
screening trial data
Z G X GX
Logistic
Estimate 0.018 0.297 -0.165 0.124
std err 0.054 0.064 0.132 0.068
p-value 7:45 10 1 3:19 10 6 2:10 10 1 6:87 10 2
SPMLE, Rare
Estimate 0.024 0.321 -0.175 0.138
std err (asymptotic) 0.054 0.067 0.134 0.055
p-value (asymptotic) 6:60 10 1 1:62 10 6 1:91 10 1 1:16 10 2
SPMLE, 1 known
Estimate 0.022 0.313 -0.174 0.141
std err (asymptotic) 0.054 0.065 0.133 0.055
p-value (asymptotic) 6:78 10 1 1:64 10 6 1:93 10 1 1:13 10 2
Logistic is ordinary logistic regression; SPMLE, Rare is our method using the rare
disease approximation with unknown 1; SPMLE, 1 known is our method when the
disease rate is known in the source population (1 = 3:56%); std err is the asymptotic
standard error estimate; Z is the main eect for age; G and X are the main eects
for the polygenic risk score (G) and the environmental variable X (age at menarche >
13), respectively; GX is the gene{environment interaction.
Using phased haplotypes from subjects of European descent from 1000 Genomes (The
1000 Genomes Project Consortium, 2015) and HapMap (Gibbs et al., 2003), no evidence
of linkage disequilibrium was found: the maximum R2 was 0.1 and the minimum q-value
was 0.85. Finally, a 2014 study examined the relationship between age at menarche and
10 of the 21 SNPs used to create our polygenic risk score, none of which were found to 270
inuence age at menarche (Andersen et al., 2014).
Table 2 presents the results for the cases that 1 is unknown and known, respectively: as
remarked upon previously, the results are very similar. To provide a basis for comparison
because of the very dierent scales of the variables, the variable age at baseline was
standardized to have mean zero and standard deviation one. In addition, we standardized 275
some of the coecient estimates so that G was multiplied by the standard deviation of
the polygenic risk score, and GX was multiplied by the standard deviation of X times
the polygenic risk score.
As expected from the known association of the single nucleotide polymorphisms with
risk of breast cancer, the polygenic risk score was strongly associated with breast cancer 280
status of the women in the study. Standard logistic regression analysis reveals some
evidence for interaction of the polygenic risk score with age-at-menarche, but the result
was not statistically signicant at the 0:05 level. When the analysis was done under the
gene{environment independence assumption, the evidence of interaction appeared to be
stronger. 285
The coecient estimate for the interaction term is slightly larger for our semipara-
metric methods than that for logistic regression. Also, the asymptotic standard error
estimate of logistic regression is approximately 23% larger than our methods, indicating
a variance increase of  50%. Although not listed here, the balanced bootstrap men-
tioned in x32 has very similar standard error estimates. In that bootstrap, 33% of the 290
10
time, the logistic interaction estimate was actually greater than that of the disease rate
known estimate.
5. Discussion and Extensions
We have proposed a general method for using retrospective likelihoods for studying
gene{environment interactions involving multiple markers, a method that does not re-295
quire any distributional assumption of the multivariate genotype distribution. Some-
times, one may consider modeling multi{marker gene{environment interactions using an
underlying polygenic risk score, which is a weighted combination of numerous genetic
markers where the weights are pre-determined from previous association studies. In such
situations, the polygenic risk score might be assumed to follow approximately a normal300
distribution in the underlying population and the prole likelihood method of Chatterjee
& Carroll (2005) can be used with appropriate modication by replacing the parametric
multinomial distribution for a single nucleotide polymorphism genotype by a parametric
normal distribution for the polygenic risk score, see also Chen et al. (2008) and Lin &
Zeng (2009). In general, however, when an investigator desires to explore complex models305
for multivariate gene{environment interactions retaining separate parameters for distinct
single nucleotide polymorphisms or for distinct genetic proles dened by combinations
of correlated single nucleotide polymorphisms, then one cannot avoid dealing with com-
plex multivariate genotype distributions, something that is not easy to specify through
parametric models.310
Our methods are types of semiparametric plug-in estimators, and thus have certain
features in common with the work of Newey (1994), namely that the prole likelihood
has the nonparametric component R(x;
) in (4) that is estimated by (5). Generally,
however, such plug-in estimators are not semiparametric ecient. We believe it will be
possible to create an ecient semiparametric estimator by modifying the work of Ma315
(2010): we are exploring this and its computational aspects, which may be daunting.
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